Preparation of protective antigen
View Patent ↗A polynucleotide sequence is provided comprising a nucleic acid sequence encoding recombinant Protective Antigen (rPA). Also provided are expression vectors and host cells comprising the polynucleotide sequence of the invention, and methods for producing rPA.
1. An isolated polynucleotide having at least 90% sequence identity to SEQ ID NO: 36,
wherein the isolated polynucleotide is an rPA polynucleotide,
with the proviso that the isolated polynucleotide does not comprise the nucleic acid sequence of SEQ ID NO: 1.
2. An isolated polynucleotide according to claim 1 , having at least 93% sequence identity to SEQ ID NO: 36.
3. An isolated polynucleotide according to claim 1 , having at least 95% sequence identity to SEQ ID NO: 36.
4. An isolated polynucleotide according to claim 1 , having at least 90% sequence identity to a SEQ ID NO. selected from the group consisting of SEQ ID NOs: 46, 56, 66, 76, 86 and 96.
5. An isolated polynucleotide according to claim 1 , comprising at least 1766 nucleotides.
6. An isolated polynucleotide according to claim 1 , having at least 90% identity to SEQ ID NO: 1.
7. An isolated polynucleotide according to claim 1 , further comprising a polynucleotide encoding a secretion sequence.
8. An isolated polynucleotide according to claim 7 , wherein said secretion sequence is selected from ompA, ompT, ompF, pelB, phoA, lamB, beta lactamase, staphylococcus aureus protein A, bacillus subtilis endoglucanase, murine RNAse, human growth hormone, enterotoxin ST-II, LT-A or LT-B, and cpg.
9. An isolated polynucleotide according to claim 7 , wherein said secretion sequence is for periplasmic translocation of the expressed polypeptide from a bacterial host cell cytoplasm.
10. An isolated polynucleotide according to claim 7 , wherein said secretion sequence is for extracellular translocation of the expressed polypeptide from a bacterial host cell cytoplasm.
11. An isolated polynucleotide according to claim 9 , wherein said secretion sequence is cleavable from the expressed polypeptide during periplasmic translocation.
12. An isolated polynucleotide according to claim 10 , wherein said secretion sequence is cleavable from the expressed polypeptide during extracellular translocation.
13. An isolated polynucleotide according to claim 7 , wherein the secretion sequence is a cpg leader sequence encoded by SEQ ID NO: 3.
14. An isolated polynucleotide according to claim 1 , wherein the isolated polynucleotide has a 3′ and a 5′ end, and wherein the isolated polynucleotide has a codon encoding a methionine residue at the 5′ end.
15. An isolated polynucleotide according to claim 1 , having a nucleic acid sequence selected from SEQ ID NOs: 9-105.
16. An expression vector comprising the polynucleotide of claim 1 .
17. An expression vector according to claim 16 , comprising a promoter that is selected so as to ensure that an rPA polypeptide is highly expressed.
18. An expression vector according to claim 17 , wherein said promoter is a malate dehydrogenase (mdh) promoter.
19. An expression vector according to claim 16 , further comprising a selectable marker.
20. An expression vector according to claim 16 , wherein said vector is selected from a pET vector, a pTrKHis vector and a pMTL vector.
21. An expression vector according to claim 16 , wherein said vector expresses the polynucleotide in the absence of a chemical inducer.
22. A host cell comprising the expression vector according to claim 16 .
23. A host cell according to claim 22 , wherein said host is an E. coli cell.
24. A host cell according to claim 23 , wherein said E. coli cell is E. coli RV308.
25. An isolated polynucleotide according to claim 1 , having 91 to 99% sequence identity to SEQ ID NO: 1.